[Treatment of supraventricular tachyarrhythmias: drugs or ablation?].
Chimienti
M
M
Dipartimento di Medicina Interna-Università Degli Studi di Pavia.
Barbieri
S
S
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000601:surgery; D001282:Atrial Flutter / Q000188:drug therapy / Q000601:surgery; D017115:Catheter Ablation / Q000009:adverse effects / Q000191:economics; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D006801:Humans; D015337:Multicenter Studies as Topic; D013610:Tachycardia / Q000188:drug therapy / Q000601:surgery; D013617:Tachycardia, Supraventricular / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy / Q000601:surgery
D000889:Anti-Arrhythmia Agents
Trattamento delle tachiaritmie sopraventriocolari: farmaci o ablazione?